FreshRecalls

FDAClass I · Medical device · Recalled June 10, 2026

Ivenix Infusion System (IIS) recall — Fresenius Kabi USA, LLC

Hazard: Fresenius Kabi has been made aware via customer complaints that dropping or severe jarring of the Ivenix LVP may cause damage to internal components that may not be apparent or readily visible and the devices therefore remained in service. More specifically, drops or jarring on a hard surface can cause the touchscreen input cable to loosen, resulting in unintended touchscreen behavior on the LVP, including random screen touches and/or lack of screen responsiveness to user input. Under the reported failure condition, unintended touch inputs may register at arbitrary screen locations without user interaction. These inputs occur intermittently and without a predictable pattern.

Class I: most serious — reasonable probability of serious health consequences or death.

Official recall ID
Z-2224-2026
Brand
Fresenius Kabi USA
Classification
Class I
Units affected
18,444
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Description

Ivenix Infusion System (IIS), Large Volume Pump, Model Number: LVP-0004

Affected products

Companies & origin

Recalling firm location
North Andover, MA, United States
Firm address
50 High St Ste 50, 01845-2620

Identifying details (verbatim from the notice)

Product codes / lots
Model Number: LVP-0004; UDI-DI: 00811505030320; All Serial/Lot Numbers:
Distribution
Domestic: CA, CO, FL, GA, ID, IL, MD, MI, MI , MN, MO, MS, NE, NJ, NV, OK, OR, SC, TX, VA, WA, WI, WI;
Firm notified the public via
E-Mail
FDA event ID
98945
Recall initiated
May 6, 2026
FDA classified
May 29, 2026
FDA report date
June 10, 2026

Source: U.S. Food & Drug Administration. This page mirrors the official public-domain record verbatim; the linked government source is authoritative. Source last checked July 24, 2026 at 3:00 AM UTC.

Report a data error on this page